Pyridazines 79. Novel oxazolo[3',2':1,2]pyrrolo[3,4-d]pyridazines and imidazolo[1'2':1,2]pyrrolo[3,4-d]pyridazines: synthesis and biological evaluation. 1996

B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
Institute of Pharmaceutical Chemistry, University of Innsbruck, Austria.

UI MeSH Term Description Entries
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
July 2023, International journal of molecular sciences,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
August 2010, Bioorganic & medicinal chemistry letters,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
April 2015, Chemistry & biodiversity,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
June 2019, Bioorganic & medicinal chemistry letters,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
January 2001, Archiv der Pharmazie,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
September 2013, Archiv der Pharmazie,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
June 2017, Bioorganic & medicinal chemistry letters,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
June 2016, Bioorganic & medicinal chemistry,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
May 2011, Acta crystallographica. Section E, Structure reports online,
B Barth, and M Dierich, and G Heinisch, and B Matuszczak, and K Mereiter, and J Soder, and H Stoiber
April 1979, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!